Key Points Zoetis' newer launches can help address problems with some existing products. Regeneron is finding ways to overcome increased competition. 10 stocks we like better than Zoetis › Zoetis (NYSE: ZTS) and Regeneron Pharmaceuticals (NASDAQ: REGN) are two healthcare leaders that have lagged broader equities over the past 12 months, as both encountered headwinds that led to worse-than-expected financial results. However, following recent developments, Zoetis and Regeneron look much better than t ...